Respiratory Syncytial Virus Glycoprotein F Antibodies
We offer Respiratory Syncytial Virus Glycoprotein F Antibodies for use in common research applications: ELISA, Immunofluorescence, Immunohistochemistry, Western Blot. Each Respiratory Syncytial Virus Glycoprotein F Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our Respiratory Syncytial Virus Glycoprotein F Antibodies can be used in a variety of model species: Human, Viral, Virus. Use the list below to choose the Respiratory Syncytial Virus Glycoprotein F Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our Respiratory Syncytial Virus Glycoprotein F monoclonal antibodies.
Alternate Names for Respiratory Syncytial Virus Glycoprotein F Antibodies
anti-Respiratory Syncytial Virus Glycoprotein F antibody
13 Results for "respiratory-syncytial-virus-glycoprotein-f" in Primary Antibodies
![Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (RSV 11-6-F9) [NBP2-50394] - The antigen was gradient purified RSN-A2 virus (subgroup A). First antibodies: Lane “Hus”: RSV convalescent human sera; Lane “MAb”: 11-6-F9 antibody. The antigen was analysed by electrophoresis using non-reducing conditions (SDS alone) for Lane “MAb” and reducing conditions for Lane “Hus” as described in Gimenez et al. (1986). The identity and molecular weight of the protein target of this antibody was validated by including within the immunoblot assay (as a marker) a convalescent serum sample from a RS virus infected patient. The protein specificities of the antibodies induced in the human convalescent serum is described in Gimenez et al. (1987).](http://images.novusbio.com/fullsize/Respiratory-Syncytial-Virus-Glycoprotein-F-Antibody-RSV-11-6-F9-Western-Blot-NBP2-50394-img0001.jpg "Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (RSV 11-6-F9) [NBP2-50394] - The antigen was gradient purified RSN-A2 virus (subgroup A). First antibodies: Lane “Hus”: RSV convalescent human sera; Lane “MAb”: 11-6-F9 antibody. The antigen was analysed by electrophoresis using non-reducing conditions (SDS alone) for Lane “MAb” and reducing conditions for Lane “Hus” as described in Gimenez et al. (1986). The identity and molecular weight of the protein target of this antibody was validated by including within the immunoblot assay (as a marker) a convalescent serum sample from a RS virus infected patient. The protein specificities of the antibodies induced in the human convalescent serum is described in Gimenez et al. (1987).")
![Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (RSV 11-2-F3) [NBP2-50412] - The antigen present in all lanes was gradient purified RSN-A2 virus (subgroup A). First antibodies: lanes “mAb”: 11-2-F3 antibody; lanes “Hus”: RS virus convalescent human sera. Panel A: Antigen analysed by electrophoresis using reducing conditions (SDS and mercapthoethanol). Panel B: Antigen analysed by electrophoresis using non reducing conditions (SDS only) (Gimenez et al., 1986). The identity and molecular weight of the protein target of this antibody was validated by including within the immunoblot assay (as a marker) a convalescent serum sample from a RS virus infected patient.](http://images.novusbio.com/fullsize/Respiratory-Syncytial-Virus-Glycoprotein-F-Antibody-RSV-11-2-F3-Western-Blot-NBP2-50412-img0001.jpg "Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (RSV 11-2-F3) [NBP2-50412] - The antigen present in all lanes was gradient purified RSN-A2 virus (subgroup A). First antibodies: lanes “mAb”: 11-2-F3 antibody; lanes “Hus”: RS virus convalescent human sera. Panel A: Antigen analysed by electrophoresis using reducing conditions (SDS and mercapthoethanol). Panel B: Antigen analysed by electrophoresis using non reducing conditions (SDS only) (Gimenez et al., 1986). The identity and molecular weight of the protein target of this antibody was validated by including within the immunoblot assay (as a marker) a convalescent serum sample from a RS virus infected patient.")